Search

everythinglearnresearchcommunity

for

Search:↓

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Flutamide reduces hair growth better but has more side effects.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

New treatments for PCOS focus on managing symptoms and improving fertility.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Isotretinoin may cause temporary, reversible facial hair growth in some women.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.